Redmile Group, LLC Zoetis Inc. Transaction History

Redmile Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$79.28 - $95.27 $20.1 Million - $24.1 Million	-253,300 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$83.5 - $93.23 $350,700 - $391,566	4,200 Added 1.69%	253,300 $23.2 Million
Q2 2018 Aug 14, 2018	BUY	$79.9 - $89.2 $19.9 Million - $22.2 Million	249,100 New	249,100 $21.2 Million

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.